Pancreatic Cancer Research

ResearcherThe Royal Melbourne HospitalActive in the last 2 years

John Raymond Zalcberg

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6624-0782; OpenAlex author ID A5008173055. Sources: OpenAlex.

Their work

Papers
25 (first author 4, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
75
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 2 papers · 2022: 6 papers · 2023: 2 papers · 2024: 1 paper · 2025: 6 papers · 2026: 4 papers

Papers 25

  1. Endoscopic ultrasound molecular evaluation of pancreatic cancer trial to profile molecular landscape of inoperable pancreatic ductal adenocarcinoma. Co-author DOI 10.1055/a-2733-1068↗
  2. Factors Associated With Pancreatectomy Among Australians With Pancreatic Cancer: A Population-Based Study. Co-author DOI 10.1111/ans.70788↗
  3. Stakeholder Consensus Selection of Data Elements and Indicators for a Pancreatic Cancer Surgical Outcomes Registry in Australia and Aotearoa New Zealand: Modif… Co-author DOI 10.1111/ans.70789↗
  4. The sensitivity of decision support tools for identifying patients with pancreatic cancer: an observational study. Co-author DOI 10.3399/bjgpo.2025.0142↗
  5. Do routine narrative style CT reports provide sufficient information to adequately stage pancreatic cancer. Co-author DOI 10.1016/j.hpb.2025.05.001↗
  6. Aiming for high quality of care for completed resections and improved margin status in pancreatic cancer surgery. Last author DOI 10.1016/j.pan.2025.09.029↗
  7. Relationship between pancreatic cancer resection rate and survival at population level: systematic review. Co-author DOI 10.1093/bjsopen/zraf007↗
  8. Barriers and hurdles delaying governance approval for an ethically approved nationwide clinical trial in pancreatic cancer. Co-author DOI 10.1111/ans.19296↗
  9. Re: Simulating the healthcare workforce impact and capacity for pancreatic cancer care in Victoria: a model-based analysis. First author DOI 10.1111/ans.19370↗
  10. Assessing the impact of an intensive dietitian-led telehealth intervention focusing on nutritional adequacy, symptom control and optional supplemental jejunal … Co-author DOI 10.1186/s12937-025-01113-9↗
  11. Filling the information void for the benefit of patients: why AANZ need a population-based clinical quality registry for pancreatic cancer surgery. First author DOI 10.1111/ans.19265↗
  12. Characteristics of patients diagnosed with pancreatic cancer who access palliative care: An observational study. Co-author DOI 10.1007/s11136-023-03425-x↗
  13. Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey. Co-author DOI 10.1016/j.hpb.2023.07.883↗
  14. The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancer. Last author DOI 10.1016/j.hpb.2021.11.005↗
  15. Prognostic models to predict survival in patients with pancreatic cancer: a systematic review. Co-author DOI 10.1016/j.hpb.2022.01.011↗
  16. National clinical quality registry for pancreatic cancer - the time is nigh. First author DOI 10.1111/ans.17747↗
  17. Synoptic CT scan reporting of pancreatic adenocarcinoma to align with international consensus guidelines on surgical resectability: a Victorian pilot. Co-author DOI 10.1111/ans.17999↗
  18. Landscape of clinical trials across the pancreatic cancer care continuum: an Australian perspective. Co-author DOI 10.5694/mja2.51756↗
  19. Systematic review of the predictors of health service use in pancreatic cancer. Co-author PMID 35261792↗
  20. EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy. Co-author DOI 10.3389/fonc.2021.770022↗
  21. The EUS molecular evaluation of pancreatic cancer: A prospective multicenter cohort trial. Co-author DOI 10.4103/eus-d-20-00230↗
  22. Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review. Co-author DOI 10.1016/j.hpb.2019.09.002↗
  23. Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework. Co-author DOI 10.1371/journal.pone.0243312↗
  24. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus. Co-author DOI 10.1016/j.hpb.2018.08.016↗
  25. 3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer. First author DOI 10.1016/j.ejca.2017.03.022↗

Closest collaborators

The 25 strongest of 75 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Charles H. C. Pilgrim · 14 shared papers, 2019–2025 · strength 2.24
  2. Daniel Gerald Croagh · 13 shared papers, 2019–2026 · strength 2.05
  3. Liane Ioannou · 11 shared papers, 2019–2025 · strength 1.71
  4. Benjamin P. T. Loveday · 4 shared papers, 2024–2026 · strength 1.27
  5. Elizabeth Lockie · 4 shared papers, 2024–2026 · strength 1.27
  6. Sue Evans · 9 shared papers, 2019–2025 · strength 1.22
  7. Rachel Ε. Neale · 8 shared papers, 2019–2026 · strength 1.15
  8. Andrew J. Metz · 3 shared papers, 2026 · strength 0.74
  9. Ashika D. Maharaj · 6 shared papers, 2019–2025 · strength 0.70
  10. Neil Donald Merrett · 6 shared papers, 2019–2025 · strength 0.70
  11. Kate White · 6 shared papers, 2019–2025 · strength 0.70
  12. Joanne Lundy · 4 shared papers, 2021–2026 · strength 0.64
  13. James G. Kench · 5 shared papers, 2019–2025 · strength 0.61
  14. Jennifer A. M. Philip · 5 shared papers, 2019–2023 · strength 0.55
  15. Nadia N. Khan · 3 shared papers, 2022–2023 · strength 0.51
  16. Brendan John Jenkins · 3 shared papers, 2021–2026 · strength 0.45
  17. John Albert Windsor · 2 shared papers, 2026 · strength 0.45
  18. Mary A. Waterhouse · 2 shared papers, 2026 · strength 0.45
  19. David Goldstein · 3 shared papers, 2022–2025 · strength 0.45
  20. David Goldstein · 4 shared papers, 2019–2021 · strength 0.38
  21. Luc te Marvelde · 2 shared papers, 2022–2023 · strength 0.35
  22. Belinda Lee · 2 shared papers, 2021–2026 · strength 0.33
  23. Manoop S. Bhutani · 2 shared papers, 2021–2026 · strength 0.33
  24. Hasna Kazi · 1 shared paper, 2025 · strength 0.33
  25. Sanjay Pandanaboyana · 1 shared paper, 2025 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.